Cited by 80Angiogenesis and VEGF in CancerCancer Cells and MetastasisLymphatic System and Diseases

Temporal multi-omics identifies LRG1 as a vascular niche instructor of metastasis

Open access
Singhal, Mahak, Gengenbacher, Nicolas, Abdul Pari, Ashik Ahmed, Kamiyama, Miki, Hai, Ling, Kuhn, Bianca J., Kallenberg, David M., Kulkarni, Shubhada R. +16 more·2021·Science Translational Medicine

Abstract

A temporal systems biology screen of premetastatic endothelial cells identified LRG1 as a therapeutic target for restricting metastases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.abe6805

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The JAK-STAT pathway regulates metastasis and tumor angiogenesis.

    “The JAK-STAT pathway is known to regulate metastasis and tumor angiogenesis35–37”

    From Endothelial Pim3 kinase protects the vascular barrier during lung metastasis (2024) · cites this paper as [37]

    The Introduction (page unavailable) says that deleting endothelial STAT3 suppressed metastatic colonization in mice, supporting a role for STAT3 signaling in metastasis. It does not establish that the JAK–STAT pathway regulates tumor angiogenesis; the Discussion (page unavailable) says LRG1 did not enhance lung endothelial-cell proliferation in this study and suggests the small metastases may have relied on vessel co-option rather than sprouting angiogenesis. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Singhal, M., Gengenbacher, N., Abdul Pari, A. A., Kamiyama, M., Hai, L., Kuhn, B. J., Kallenberg, D. M., Kulkarni, S. R., Camilli, C., Preuß, S. F., Leuchs, B., Mogler, C., Espinet, E., Besemfelder, E., Heide, D., Heikenwalder, M., Sprick, M. R., Trumpp, A., Krijgsveld, J., Schlesner, M., Hu, J., Moss, S. E., Greenwood, J., & Augustin, H. G.
Affiliations
  • German Cancer Research Center (DE)
  • Division of Vascular Oncology and Metastasis, German Cancer Research Center (DKFZ-ZMBH Alliance), 69120 Heidelberg, Germany.
  • University College London (GB)
  • Technical University of Munich (DE)
  • Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • University of Augsburg (DE)
  • Chinese Academy of Sciences (CN)
Corresponding author
  • Singhal, Mahak
  • Gengenbacher, Nicolas
  • Augustin, Hellmut G.
Venue
Science Translational Medicine
Published
2021-09
Volume
13
Issue
609
Pages
eabe6805-eabe6805
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W3197197951
Cited by
80
References
68
Citations by year
2026: 7 · 2025: 15 · 2024: 26 · 2023: 17 · 2022: 12 · 2021: 3
FWCI
4.92
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
  • OPUS (Augsburg University) (submittedVersion)
Funders
  • Wellcome Trust (206413/B/17/Z, 206413/Z/17/Z)
  • Medical Research Council (MR/N006410/1)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
Keywords
LRG1, lung metastasis, tumor microenvironment, vascular niche, adjuvant therapy, therapeutic target
MeSH terms
Glycoproteins, Humans, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review